Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Abbate

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|July 1, 2020
Intratumoral Administration of a Novel Cytotoxic Formulation with Strong Tissue Dispersive Properties Regresses Tumor Growth and Elicits Systemic Adaptive Immunity in In Vivo ModelsLewis H Bender, Franco Abbate, Ian B Walters
Journal of Anatomy|June 19, 2007
Age-dependent changes in the pigeon bursa of Fabricius vasculature: a comparative study using light microscopy and scanning electron microscopy of vessel castsFranco Abbate, Christiane Pfarrer, Carolyn J P Jones, et al.
Pigment Cell & Melanoma Research|June 6, 2017
FBXW7 inactivation in a Braf<sup>V600E</sup> -driven mouse model leads to melanoma developmentIraz T Aydin, Franco Abbate, Geena Susan Rajan, et al.
Plos One|June 7, 2014
Insulin-like-growth-factor-binding-protein-3 (IGFBP-3) contrasts melanoma progression in vitro and in vivoAntimo Naspi, Vincenzo Panasiti, Franco Abbate, et al.
Pigment Cell & Melanoma Research|April 18, 2018
FBXW7 regulates a mitochondrial transcription program by modulating MITFFranco Abbate, Brateil Badal, Karen Mendelson, et al.
Cell Death & Disease|January 20, 2018
Dual suppression of inner and outer mitochondrial membrane functions augments apoptotic responses to oncogenic MAPK inhibitionMadhavika N Serasinghe, Jesse D Gelles, Kent Li, et al.
Frontiers in Immunology|March 19, 2025
The C/EBPβ antagonist peptide lucicebtide (ST101) induces macrophage polarization toward a pro-inflammatory phenotype and enhances anti-tumor immune responsesClaudio Scuoppo, Rick Ramirez, Siok F Leong, et al.
Ebiomedicine|October 30, 2025
Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation studyJacob S Thomas, Lillian L Siu, Matthew Ingham, et al.
JCI Insight|May 5, 2017
Transcriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulationBrateil Badal, Alexander Solovyov, Serena Di Cecilia, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|July 1, 2020
Intratumoral Administration of a Novel Cytotoxic Formulation with Strong Tissue Dispersive Properties Regresses Tumor Growth and Elicits Systemic Adaptive Immunity in In Vivo ModelsLewis H Bender, Franco Abbate, Ian B Walters
Journal of Anatomy|June 19, 2007
Age-dependent changes in the pigeon bursa of Fabricius vasculature: a comparative study using light microscopy and scanning electron microscopy of vessel castsFranco Abbate, Christiane Pfarrer, Carolyn J P Jones, et al.
Pigment Cell & Melanoma Research|June 6, 2017
FBXW7 inactivation in a Braf<sup>V600E</sup> -driven mouse model leads to melanoma developmentIraz T Aydin, Franco Abbate, Geena Susan Rajan, et al.
Plos One|June 7, 2014
Insulin-like-growth-factor-binding-protein-3 (IGFBP-3) contrasts melanoma progression in vitro and in vivoAntimo Naspi, Vincenzo Panasiti, Franco Abbate, et al.
Pigment Cell & Melanoma Research|April 18, 2018
FBXW7 regulates a mitochondrial transcription program by modulating MITFFranco Abbate, Brateil Badal, Karen Mendelson, et al.
Cell Death & Disease|January 20, 2018
Dual suppression of inner and outer mitochondrial membrane functions augments apoptotic responses to oncogenic MAPK inhibitionMadhavika N Serasinghe, Jesse D Gelles, Kent Li, et al.
Frontiers in Immunology|March 19, 2025
The C/EBPβ antagonist peptide lucicebtide (ST101) induces macrophage polarization toward a pro-inflammatory phenotype and enhances anti-tumor immune responsesClaudio Scuoppo, Rick Ramirez, Siok F Leong, et al.
Ebiomedicine|October 30, 2025
Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation studyJacob S Thomas, Lillian L Siu, Matthew Ingham, et al.
JCI Insight|May 5, 2017
Transcriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulationBrateil Badal, Alexander Solovyov, Serena Di Cecilia, et al.
Pageof 1